Literature DB >> 9708036

Alterations of the vascular and the myocardial guanylate cyclase/cGMP-system induced by long-term hypertension in rats.

G Kojda1, K Kottenberg, A Hacker, E Noack.   

Abstract

NO as produced by NO-synthases (NOS) contributes to the regulation of cardiovascular functions. In hypertension, there is a reduced production and/or activity of endogenous NO in the vasculature. We investigated if hypertension alters the NO-sensitivity of soluble guanylate cyclase (sGC) in blood vessels and heart muscle isolated from 15 month old spontaneously hypertensive rats (SHR15) and normal Wistar rats (WIS). Inhibition of NOS by 1 mM N omega-nitro-L-arginine decreased dP/dtmax in WIS (-27.6 +/- 3.4%) and SHR15 (-26.0 +/- 4.4%), while stimulation of NOS with 1 mM L-arginine increased dP/dtmax in WIS (9.9 +/- 0.7%) and SHR15 (8.9 +/- 2.3%). The positive inotropic response to 0.1 microM glyceryl trinitrate (GTN) was comparable in WIS (dP/dtmax: 4.5 +/- 1.7%) and SHR15 (dP/dtmax: 3.75 +/- 0.7%) as was the positive inotropic response to the NO-donor sodium (Z)-1-(N,N-diethylamino)diazen-1-ium-1,2-diolat (DEA/NO, 1 microM) in WIS (dP/dtmax: 10.7 +/- 2.9%) and SHR15 (dP/dtmax: 5.1 +/- 1.5%, P = 0.1873). In aortas of SHR15 we found an increased superoxide production of 19.4 +/- 1.7 nM/mg/min (WIS: 6.1 +/- 0.6 nM/mg/min) in the smooth muscle and the endothelial layer. Endothelium-dependent relaxation by acetylcholine was markedly impaired in SHR15 as was the vasorelaxant activity of S-nitroso-N-acetyl-D,L-penicillamine (SNAP), pentaerythritol tetranitrate and GTN. Maximal cGMP-production by sGC isolated from the lung and stimulated with SNAP (0.5 mM) was much lower in SHR15 (115 +/- 14 pmol/mg/min) than in WIS (348 +/- 36 pmol/mg/min). We suggest that hypertension is associated with a reduced activity of the sGC/cGMP-system in the vasculature but not in the heart muscle. Our results provide the first evidence that excess superoxide production in hypertension may trigger a desensitization of vascular sGC.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9708036     DOI: 10.1016/s0031-6865(97)00044-7

Source DB:  PubMed          Journal:  Pharm Acta Helv        ISSN: 0031-6865


  7 in total

Review 1.  NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

Authors:  Oleg V Evgenov; Pál Pacher; Peter M Schmidt; György Haskó; Harald H H W Schmidt; Johannes-Peter Stasch
Journal:  Nat Rev Drug Discov       Date:  2006-09       Impact factor: 84.694

2.  The nitric oxide donor pentaerythritol tetranitrate can preserve endothelial function in established atherosclerosis.

Authors:  A Hacker; S Müller; W Meyer; G Kojda
Journal:  Br J Pharmacol       Date:  2001-04       Impact factor: 8.739

3.  Downregulation of vascular soluble guanylate cyclase induced by high salt intake in spontaneously hypertensive rats.

Authors:  S Kagota; A Tamashiro; Y Yamaguchi; R Sugiura; T Kuno; K Nakamura; M Kunitomo
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

4.  Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase.

Authors:  M Oppermann; V T-V Dao; T Suvorava; M Bas; G Kojda
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

5.  The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study.

Authors:  Aamer Sandoo; George D Kitas; Douglas Carroll; Jet J C S Veldhuijzen van Zanten
Journal:  Arthritis Res Ther       Date:  2012-05-17       Impact factor: 5.156

Review 6.  Does the sympathetic nervous system contribute to the pathophysiology of metabolic syndrome?

Authors:  Marina C Dos Santos Moreira; Izabella S de Jesus Pinto; Aline A Mourão; James O Fajemiroye; Eduardo Colombari; Ângela A da Silva Reis; André H Freiria-Oliveira; Marcos L Ferreira-Neto; Gustavo R Pedrino
Journal:  Front Physiol       Date:  2015-08-25       Impact factor: 4.566

7.  Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study.

Authors:  Aamer Sandoo; Neil Chanchlani; James Hodson; Jacqueline P Smith; Karen M Douglas; George D Kitas
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.